{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:56:59Z","timestamp":1790517419882,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009726","name":"Foundation for Angelman Syndrome Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11136-026-04407-5","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:07:23Z","timestamp":1790510843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishing meaningful score differences for the observer-reported communication ability (ORCA) measure using the scale judgment approach with caregivers of individuals with Angelman syndrome"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6315-9129","authenticated-orcid":false,"given":"Abigail","family":"Rader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Weinfurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Panagoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson","family":"Berent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Namestnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce B.","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"issue":"9","key":"4407_CR1","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/ajmg.a.36058","volume":"161a","author":"LG Mertz","year":"2013","unstructured":"Mertz, L. G., Christensen, R., Vogel, I., Hertz, J. M., Nielsen, K. B., Gr\u00f8nskov, K., & \u00d8stergaard, J. R. (2013). Angelman syndrome in Denmark. Birth incidence, genetic findings, and age at diagnosis. American Journal of Medical Genetics Part A, 161a(9), 2197\u20132203.","journal-title":"Am J Med Genet A"},{"key":"4407_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/TACG.S57386","volume":"7","author":"LM Bird","year":"2014","unstructured":"Bird, L. M. (2014). Angelman syndrome: Review of clinical and molecular aspects. The Application of Clinical Genetics, 7, 93\u2013104.","journal-title":"Appl Clin Genet"},{"issue":"2","key":"4407_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/jmg.40.2.87","volume":"40","author":"J Clayton-Smith","year":"2003","unstructured":"Clayton-Smith, J., & Laan, L. (2003). Angelman syndrome: A review of the clinical and genetic aspects. Journal of Medical Genetics, 40(2), 87\u201395.","journal-title":"Journal of Medical Genetics"},{"issue":"3","key":"4407_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1891\/0730-0832.36.3.142","volume":"36","author":"D Bonello","year":"2017","unstructured":"Bonello, D., Camilleri, F., & Calleja-Agius, J. (2017). Angelman syndrome: Identification and management. Neonatal Network, 36(3), 142\u2013151.","journal-title":"Neonatal Network"},{"issue":"3","key":"4407_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s13311-015-0361-y","volume":"12","author":"SS Margolis","year":"2015","unstructured":"Margolis, S. S., Sell, G. L., Zbinden, M. A., & Bird, L. M. (2015). Angelman syndrome. Neurotherapeutics, 12(3), 641\u2013650.","journal-title":"Neurotherapeutics"},{"issue":"10","key":"4407_CR6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrneurol.2016.133","volume":"12","author":"K Buiting","year":"2016","unstructured":"Buiting, K., Williams, C., & Horsthemke, B. (2016). Angelman syndrome: Insights into a rare neurogenetic disorder. Nature Reviews Neurology, 12(10), 584\u2013593.","journal-title":"Nature Reviews Neurology"},{"issue":"12","key":"4407_CR7","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/humu.22687","volume":"35","author":"B Sadikovic","year":"2014","unstructured":"Sadikovic, B., Fernandes, P., Zhang, V. W., Ward, P. A., Miloslavskaya, I., Rhead, W., Rosenbaum, R., Gin, R., Roa, B., & Fang, P. (2014). Mutation update for UBE3A variants in Angelman syndrome. Human Mutation, 35(12), 1407\u20131417.","journal-title":"Human Mutation"},{"issue":"4","key":"4407_CR8","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ymthe.2023.01.013","volume":"31","author":"H O\u2019Geen","year":"2023","unstructured":"O\u2019Geen, H., Beitnere, U., Garcia, M. S., Adhikari, A., Cameron, D. L., Fenton, T. A., Copping, N. A., Deng, P., Lock, S., Halmai, J., Villegas, I. J., Liu, J., Wang, D., Fink, K. D., Silverman, J. L., & Segal, D. J. (2023). Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model. Molecular Therapy, 31(4), 1088\u20131105.","journal-title":"Molecular Therapy"},{"issue":"12","key":"4407_CR9","doi-asserted-by":"publisher","first-page":"27221","DOI":"10.1371\/journal.pone.0027221","volume":"6","author":"JL Daily","year":"2011","unstructured":"Daily, J. L., Nash, K., Jinwal, U., Golde, T., Rogers, J., Peters, M. M., Burdine, R. D., Dickey, C., Banko, J. L., & Weeber, E. J. (2011). Adeno-associated virus-mediated rescue of the cognitive defects in a mouse model for Angelman syndrome. PLoS One, 6(12), e27221.","journal-title":"PLoS One"},{"issue":"12","key":"4407_CR10","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/hmg\/ddab104","volume":"30","author":"A Adhikari","year":"2021","unstructured":"Adhikari, A., Copping, N. A., Beegle, J., Cameron, D. L., Deng, P., O\u2019Geen, H., Segal, D. J., Fink, K. D., Silverman, J. L., & Anderson, J. S. (2021). Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells. Human Molecular Genetics, 30(12), 1067\u20131083.","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"4407_CR11","doi-asserted-by":"publisher","first-page":"207958","DOI":"10.1212\/WNL.0000000000207958","volume":"102","author":"AT Berg","year":"2024","unstructured":"Berg, A. T., Ludwig, N. N., Wojnaroski, M., Chapman, C. A. T., Hommer, R., Conecker, G., Hecker, J. Z., & Downs, J. (2024). FDA patient-focused drug development guidances: Considerations for trial readiness in rare developmental and epileptic encephalopathies. Neurology, 102(1), e207958.","journal-title":"Neurology"},{"issue":"4","key":"4407_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s10578-020-01051-z","volume":"52","author":"T Willgoss","year":"2021","unstructured":"Willgoss, T., Cassater, D., Connor, S., Krishnan, M. L., Miller, M. T., Dias-Barbosa, C., Phillips, D., McCormack, J., Bird, L. M., Burdine, R. D., Claridge, S., & Bichell, T. J. (2021). Measuring what matters to individuals with angelman syndrome and their families: Development of a patient-centered disease concept model. Child Psychiatry And Human Development, 52(4), 654\u2013668.","journal-title":"Child Psychiatry And Human Development"},{"issue":"11","key":"4407_CR13","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/dmcn.14257","volume":"61","author":"E Pearson","year":"2019","unstructured":"Pearson, E., Wilde, L., Heald, M., Royston, R., & Oliver, C. (2019). Communication in Angelman syndrome: A scoping review. Developmental Medicine & Child Neurology, 61(11), 1266\u20131274.","journal-title":"Developmental Medicine & Child Neurology"},{"key":"4407_CR14","unstructured":"Sparrow, S. S., Cicchetti, D. V., & Saulnier, C. A. (2016). Vineland adaptive behavior scales, third edition (Vineland-3) comprehensive interview form report [Sample report]. San Antonio, TX."},{"key":"4407_CR15","doi-asserted-by":"crossref","unstructured":"Bayley, N., & Aylward, G. P. (2019). Bayley scales of infant and toddler development, fourth edition. Pearson Education, Inc.","DOI":"10.1007\/978-3-319-57111-9_1522"},{"key":"4407_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/PRM-2010-0144","volume":"3","author":"C Rowland","year":"2010","unstructured":"Rowland, C., & Fried-Oken, M. (2010). Communication matrix: A clinical and research assessment tool targeting children with severe communication disorders. Journal of Pediatric Rehabilitation Medicine, 3, 319\u2013329.","journal-title":"Journal of pediatric rehabilitation medicine"},{"issue":"3","key":"4407_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1352\/1944-7558-128.3.185","volume":"128","author":"CK Zigler","year":"2023","unstructured":"Zigler, C. K., Lucas, N., McFatrich, M., Gordon, K. L., Jones, H. N., Berent, A., Panagoulias, J., Evans, P., & Reeve, B. B. (2023). Exploring communication ability in individuals with Angelman syndrome: Findings from qualitative interviews with caregivers. American Journal on Intellectual and Developmental Disabilities, 128(3), 185\u2013203.","journal-title":"American Journal on Intellectual and Developmental Disabilities"},{"key":"4407_CR18","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11136-012-0344-y","volume":"22","author":"BB Reeve","year":"2013","unstructured":"Reeve, B. B., Wyrwich, K. W., Wu, A. W., Velikova, G., Terwee, C. B., Snyder, C. F., Schwartz, C., Revicki, D. A., Moinpour, C. M., & McLeod, L. D. (2013). ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Quality of Life Research, 22, 1889\u20131905.","journal-title":"Quality of Life Research"},{"issue":"8","key":"4407_CR19","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1524-4733.2009.00603.x","volume":"12","author":"M Rothman","year":"2009","unstructured":"Rothman, M., Burke, L., Erickson, P., Leidy, N. K., Patrick, D. L., & Petrie, C. D. (2009). Use of existing patient-reported outcome (PRO) instruments and their modification: The ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO task force report. Value in Health, 12(8), 1075\u20131083.","journal-title":"Value in Health"},{"issue":"1","key":"4407_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"gov, R. H. S. c. f","year":"2006","unstructured":"Health, U. D. o., Evaluation, H. S. F. C. f. D., gov, R. l. b. f. h., Health, U. D. o., Evaluation, H. S. F. C. f. B., gov, R. t. s. f. h., Health, U. D. o., Devices, H. S. F. C. f., & gov, R. H. S. c. f. (2006). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health and Quality of Life Outcomes, 4(1), 79.","journal-title":"Health and Quality of Life Outcomes"},{"key":"4407_CR21","unstructured":"U.S. Food and Drug Administration. (2023). Patient-Focused drug development. Incorporating clinical outcome assessments into endpoints for regulatory decision-making draft guidance."},{"key":"4407_CR22","doi-asserted-by":"crossref","unstructured":"Rader, A., Lin, L., Jones, H. N., Tan, W. H., Sadhwani, A., Berent, A., Friedman, B., Lucas, N., Gordon, K., & Reeve, B. B. (2026). Association of the observer-reported communication ability (ORCA) measure with established communication measures: insights from the Angelman syndrome natural history study. Journal of Autism and Developmental Disorders.","DOI":"10.1007\/s10803-026-07224-4"},{"issue":"3","key":"4407_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1352\/1944-7558-128.3.204","volume":"128","author":"CK Zigler","year":"2023","unstructured":"Zigler, C. K., Lin, L., McFatrich, M., Lucas, N., Gordon, K. L., Jones, H. N., Berent, A., Panagoulias, J., Evans, P., & Reeve, B. B. (2023). Validation of the observer-reported communication ability (ORCA) measure for individuals with Angelman syndrome. Am J Intellect Dev Disabil, 128(3), 204\u2013218.","journal-title":"Am J Intellect Dev Disabil"},{"issue":"1","key":"4407_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s41687-024-00725-9","volume":"8","author":"D Chen","year":"2024","unstructured":"Chen, D., Zigler, C. K., Lin, L., Lucas, N., McFatrich, M., Panagoulias, J., Berent, A., & Reeve, B. B. (2024). Understanding reliability of the observer-reported communication ability measure within Angelman syndrome through the lens of generalizability theory. Journal of Patient-Reported Outcomes, 8(1), 50.","journal-title":"Journal of Patient-Reported Outcomes"},{"issue":"1","key":"4407_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11136-017-1616-3","volume":"27","author":"CD Coon","year":"2018","unstructured":"Coon, C. D., & Cook, K. F. (2018). Moving from significance to real-world meaning: Methods for interpreting change in clinical outcome assessment scores. Quality of Life Research, 27(1), 33\u201340.","journal-title":"Quality of Life Research"},{"issue":"4","key":"4407_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","volume":"10","author":"R Jaeschke","year":"1989","unstructured":"Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of health status: Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10(4), 407\u2013415.","journal-title":"Controlled Clinical Trials"},{"issue":"4","key":"4407_CR27","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1177\/03635465231152484","volume":"51","author":"M Franceschini","year":"2023","unstructured":"Franceschini, M., Boffa, A., Pignotti, E., Andriolo, L., Zaffagnini, S., & Filardo, G. (2023). The minimal clinically important difference changes greatly based on the different calculation methods. The American Journal of Sports Medicine, 51(4), 1067\u20131073.","journal-title":"The American Journal of Sports Medicine"},{"issue":"1","key":"4407_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.14283\/jpad.2022.102","volume":"10","author":"CJ Lansdall","year":"2023","unstructured":"Lansdall, C. J., McDougall, F., Butler, L., Delmar, P., Pross, N., Qin, S., McLeod, L., Zhou, X., Kerchner, G., & Doody, R. (2023). Establishing clinically meaningful change on outcome assessments frequently used in trials of mild cognitive impairment due to Alzheimer\u2019s disease. The journal of prevention of Alzheimer\u2019s disease, 10(1), 9\u201318.","journal-title":"The journal of prevention of Alzheimer\u2019s disease"},{"issue":"2","key":"4407_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/17453674.2013.786634","volume":"84","author":"T Solberg","year":"2013","unstructured":"Solberg, T., Johnsen, L. G., Nygaard, \u00d8. P., & Grotle, M. (2013). Can we define success criteria for lumbar disc surgery? Estimates for a substantial amount of improvement in core outcome measures. Acta orthopaedica, 84(2), 196\u2013201.","journal-title":"Acta orthopaedica"},{"issue":"1","key":"4407_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12955-023-02157-3","volume":"21","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Xi, X., & Huang, Y. (2023). The anchor design of anchor-based method to determine the minimal clinically important difference: A systematic review. Health and Quality of Life Outcomes, 21(1), 74.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"7","key":"4407_CR31","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1038\/s41380-020-0858-6","volume":"26","author":"M Keute","year":"2021","unstructured":"Keute, M., Miller, M. T., Krishnan, M. L., Sadhwani, A., Chamberlain, S., Thibert, R. L., Tan, W. H., Bird, L. M., & Hipp, J. F. (2021). Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment. Molecular Psychiatry, 26(7), 3625\u20133633.","journal-title":"Molecular Psychiatry"},{"issue":"3","key":"4407_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/neurolint13030036","volume":"13","author":"M Sommese","year":"2021","unstructured":"Sommese, M., & Corrado, B. (2021). A comprehensive approach to rehabilitation interventions in patients with angelman syndrome: A systematic review of the literature. Neurology international, 13(3), 359\u2013370.","journal-title":"Neurology international"},{"issue":"1","key":"4407_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s41687-026-01072-7","volume":"10","author":"BB Reeve","year":"2026","unstructured":"Reeve, B. B., Lin, L., Rader, A., Lucas, N., Gordon, K. L., McFatrich, M., Berent, A., & Jones, H. N. (2026). Evaluating different scoring algorithms to assess communication ability for individuals living with Angelman syndrome: The observer-reported communication ability (ORCA) measure. Journal of Patient-Reported Outcomes, 10(1), 103.","journal-title":"Journal of Patient-Reported Outcomes"},{"issue":"1","key":"4407_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11136-015-1058-8","volume":"25","author":"D Thissen","year":"2016","unstructured":"Thissen, D., Liu, Y., Magnus, B., Quinn, H., Gipson, D. S., Dampier, C., Huang, I. C., Hinds, P. S., Selewski, D. T., Reeve, B. B., Gross, H. E., & DeWalt, D. A. (2016). Estimating minimally important difference (MID) in PROMIS pediatric measures using the scale-judgment method. Quality Of Life Research, 25(1), 13\u201323.","journal-title":"Quality Of Life Research"},{"key":"4407_CR35","doi-asserted-by":"crossref","unstructured":"Marais, I. (2012). Local dependence. In: Rasch models in health (pp. 111\u2013130).","DOI":"10.1002\/9781118574454.ch7"},{"issue":"6","key":"4407_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nmeth.1618","volume":"8","author":"B Wong","year":"2011","unstructured":"Wong, B. (2011). Points of view: Color blindness. Nature Methods, 8(6), 441\u2013441.","journal-title":"Nature Methods"},{"issue":"1","key":"4407_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1109\/JPROC.2017.2748421","volume":"106","author":"C Irvene","year":"2018","unstructured":"Irvene, C., Formby, D., Litchfield, S., & Beyah, R. (2018). HoneyBot: A honeypot for robotic systems. Proceedings of the IEEE, 106(1), 61\u201370.","journal-title":"Proceedings of the IEEE"},{"key":"4407_CR38","unstructured":"Hambleton, R. K., Swaminathan, H., & Rogers, H. J. (1991). Fundamentals of item response theory (Vol. 2). Sage."},{"key":"4407_CR39","doi-asserted-by":"crossref","unstructured":"Efron, B., & Tibshirani, R. J. (1994). An introduction to the bootstrap. Chapman and Hall\/CRC.","DOI":"10.1201\/9780429246593"},{"key":"4407_CR40","unstructured":"Rader, A., Gordon, R. B., Jones, K., Kern, H., McFatrich, J., Lucas, M., Namestnik, N., Ramachandran, A., Wright, P., Bichell, L., Parker, T. J., Flanagan, B., Bigelow, T., Rigby, B., Delagrammatikas, C., Chen, C., Lin, D., Bliss, L., Oyler, G., Goss, H., Worth, J., Still, K., Schust, K., Marfia-Ash, L., Thelen, L., Graglia, M., Summerfield, M., Bradley, N., Stephens, D., Genie, K., Baysden, M., & Zigler, C. (2024). C. Meaningful communication change in individuals with neurodevelopmental disorders: A person-centered approach to interpretation of the observer-reported communication ability (ORCA) measure in clinical trials., 31st annual conference of the international society for quality of life research. Cologne, Germany."},{"key":"4407_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s41687-026-01072-7","volume":"10","author":"BB Reeve","year":"2026","unstructured":"Reeve, B. B., Lin, L., Rader, A., Lucas, N., Gordon, K. L., McFatrich, M., Berent, A., & Jones, H. N. (2026). Evaluating different scoring algorithms to assess communication ability for individuals living with Angelman syndrome: The observer-reported communication ability (ORCA) measure. Journal of Patient-Reported Outcomes, 10, 103.","journal-title":"Journal of Patient-Reported Outcomes"},{"key":"4407_CR42","doi-asserted-by":"crossref","unstructured":"Rader, A. L., Sadhwani, L., Lucas, A., Jones, N., Namestnik, H. N., Ramachandran, A., Berent, P., Friedman, A., Gordon, B., Tan, K., & Reeve, W. H., Bryce B (2026). Caregiver meaningful score differences and meaningful score regions for the observer-reported communication ability (ORCA) measure for individuals with angelman syndrome. Value in Health.","DOI":"10.1016\/j.jval.2026.02.002"},{"issue":"4","key":"4407_CR43","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s10826-025-03043-w","volume":"34","author":"M Washington-Nortey","year":"2025","unstructured":"Washington-Nortey, M., Ohayagha, C., & Serpell, Z. (2025). Parental expectations for their children with developmental disabilities: A systematic scoping review. Journal of Child and Family Studies, 34(4), 1114\u20131134.","journal-title":"Journal of Child and Family Studies"},{"issue":"4","key":"4407_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/215416471705200403","volume":"52","author":"HH Bush","year":"2017","unstructured":"Bush, H. H., Cohen, S. R., Eisenhower, A. S., & Blacher, J. (2017). Parents\u2019 educational expectations for young children with autism spectrum disorder. Education and Training in Autism and Developmental Disabilities, 52(4), 357\u2013368.","journal-title":"Education and Training in Autism and Developmental Disabilities"},{"issue":"21\u201322","key":"4407_CR45","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1080\/09638280412331280271","volume":"26","author":"R Didden","year":"2004","unstructured":"Didden, R., Korzilius, H., Duker, P., & Curfs, L. (2004). Communicative functioning in individuals with Angelman syndrome: A comparative study. Disability and Rehabilitation, 26(21\u201322), 1263\u20131267.","journal-title":"Disability and Rehabilitation"},{"issue":"1","key":"4407_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/14417040500459684","volume":"8","author":"N Jolleff","year":"2006","unstructured":"Jolleff, N., Emmerson, F., Ryan, M., & McConachie, H. (2006). Communication skills in Angelman syndrome: Matching phenotype to genotype. Advances in Speech Language Pathology, 8(1), 28\u201333.","journal-title":"Advances in Speech Language Pathology"},{"issue":"24","key":"4407_CR47","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1001\/jama.2019.18496","volume":"322","author":"KP Weinfurt","year":"2019","unstructured":"Weinfurt, K. P. (2019). Clarifying the meaning of clinically meaningful benefit in clinical research: noticeable change vs valuable change. Journal of The American Medical Association, 322(24), 2381\u20132382.","journal-title":"Journal Of The American Medical Association"},{"key":"4407_CR48","first-page":"33","volume":"26","author":"BR Furrow","year":"2017","unstructured":"Furrow, B. R. (2017). The CRISPR-Cas9 tool of gene editing: Cheaper, faster, riskier. Annals Health L, 26, 33.","journal-title":"Annals Health L"},{"issue":"3","key":"4407_CR49","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1042\/ETLS20180146","volume":"3","author":"SA Gkazi","year":"2019","unstructured":"Gkazi, S. A. (2019). Quantifying CRISPR off-target effects. Emerging Topics in Life Sciences, 3(3), 327\u2013334.","journal-title":"Emerging Topics in Life Sciences"},{"issue":"1","key":"4407_CR50","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1038\/s41467-020-20096-1","volume":"11","author":"OL Aiyegbusi","year":"2020","unstructured":"Aiyegbusi, O. L., Macpherson, K., Elston, L., Myles, S., Washington, J., Sungum, N., Briggs, M., Newsome, P. N., & Calvert, M. J. (2020). Patient and public perspectives on cell and gene therapies: A systematic review. Nature Communications, 11(1), 6265.","journal-title":"Nature Communications"},{"issue":"1","key":"4407_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10728-012-0201-8","volume":"22","author":"S Woods","year":"2014","unstructured":"Woods, S., Hagger, L. E., & McCormack, P. (2014). Therapeutic misconception: Hope, trust and misconception in paediatric research. Health Care Analysis, 22(1), 3\u201321.","journal-title":"Health Care Analysis"},{"issue":"2","key":"4407_CR52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","volume":"61","author":"D Revicki","year":"2008","unstructured":"Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61(2), 102\u2013109.","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"4407_CR53","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1586\/erp.11.9","volume":"11","author":"MT King","year":"2011","unstructured":"King, M. T. (2011). A point of minimal important difference (MID): A critique of terminology and methods. Expert review of pharmacoeconomics & outcomes research, 11(2), 171\u2013184.","journal-title":"Expert review of pharmacoeconomics & outcomes research"},{"key":"4407_CR54","doi-asserted-by":"publisher","first-page":"701988","DOI":"10.3389\/fgene.2021.701988","volume":"12","author":"J Kruse","year":"2022","unstructured":"Kruse, J., Mueller, R., Aghdassi, A. A., Lerch, M. M., & Salloch, S. (2022). Genetic testing for rare diseases: A systematic review of ethical aspects. Frontiers in Genetics, 12, 701988.","journal-title":"Frontiers in Genetics"},{"key":"4407_CR55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejpn.2023.07.007","volume":"46","author":"BB Reeve","year":"2023","unstructured":"Reeve, B. B., Lucas, N., Chen, D., McFatrich, M., Jones, H. N., Gordon, K. L., Leiva, L. Z., Lin, L., Coenraads, M., von Hehn, J., Carpenter, R. L., Marsh, E. D., & Zigler, C. K. (2023). Validation of the observer-reported communication ability (ORCA) measure for individuals with Rett syndrome. European Journal of Paediatric Neurology, 46, 74\u201381.","journal-title":"European Journal of Paediatric Neurology"},{"key":"4407_CR56","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/jcpp.70063","volume":"67","author":"CK Zigler","year":"2025","unstructured":"Zigler, C. K., McFatrich, M., Lucas, N., Plyler, K., Zapata-Leiva, L., Gordon, K., Jones, H. N., Lin, L., Kern, J., & Radar, A. (2025). The spectrum of communication abilities in children with 12 rare neurodevelopmental disorders: a qualitative study with caregivers. Journal of Child Psychology and Psychiatry, 67, 740.","journal-title":"Journal of Child Psychology and Psychiatry"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04407-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04407-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04407-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:02:36Z","timestamp":1790514156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-026-04407-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4407"],"URL":"https:\/\/doi.org\/10.1007\/s11136-026-04407-5","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors Bryce Reeve, Nicole Lucas, Li Lin, Harrison Jones, and Kelly Gordon developed the ORCA measure. If the ORCA measure is commercially successful in the future, the developers and Duke University may benefit financially. Jennifer Panagoulias and Allyson Berent are employees of the Foundation for Angelman Syndrome Therapeutics, which funded this study. The remaining authors have no competing interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved and determined exempt by the Duke University Institutional Review Board (Pro00108588).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this study determined exempt by the Duke University Institutional Review Board and was minimal-risk research, caregivers acknowledged an information sheet describing the study prior to participation rather than formally signed consent.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Caregivers whose verbatim quotes appear in the Discussion gave the study team permission to publish those those quotes in anonymized form.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"299"}}